Ott PA - Search Results

1

Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with advanced melanoma.

Ott PA, Hamid O, Pavlick AC, Kluger H, Kim KB, Boasberg PD, Simantov R, Crowley E, Green JA, Hawthorne T, Davis TA, Sznol M, Hwu P. Ott PA, et al. J Clin Oncol. 2014 Nov 10;32(32):3659-66. doi: 10.1200/JCO.2013.54.8115. Epub 2014 Sep 29. J Clin Oncol. 2014. PMID: 25267741 Free PMC article. Clinical Trial.

2

Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma.

Ott PA, Chang JL, Oratz R, Jones A, Farrell K, Muggia F, Pavlick AC. Ott PA, et al. Chemotherapy. 2009;55(4):221-7. doi: 10.1159/000219435. Epub 2009 May 19. Chemotherapy. 2009. PMID: 19451711 Clinical Trial.

3

Novel therapeutics for melanoma.

Seetharamu N, Ott PA, Pavlick AC. Seetharamu N, et al. Among authors: ott pa. Expert Rev Anticancer Ther. 2009 Jun;9(6):839-49. doi: 10.1586/era.09.40. Expert Rev Anticancer Ther. 2009. PMID: 19496721 Review.

4

A phase II trial of the epothilone B analog ixabepilone (BMS-247550) in patients with metastatic melanoma.

Ott PA, Hamilton A, Jones A, Haas N, Shore T, Liddell S, Christos PJ, Doyle LA, Millward M, Muggia FM, Pavlick AC. Ott PA, et al. PLoS One. 2010 Jan 20;5(1):e8714. doi: 10.1371/journal.pone.0008714. PLoS One. 2010. PMID: 20098694 Free PMC article. Clinical Trial.

5

Mucosal melanomas: a case-based review of the literature.

Seetharamu N, Ott PA, Pavlick AC. Seetharamu N, et al. Among authors: ott pa. Oncologist. 2010;15(7):772-81. doi: 10.1634/theoncologist.2010-0067. Epub 2010 Jun 22. Oncologist. 2010. PMID: 20571149 Free PMC article. Review.

6

A phase II trial of sorafenib in metastatic melanoma with tissue correlates.

Ott PA, Hamilton A, Min C, Safarzadeh-Amiri S, Goldberg L, Yoon J, Yee H, Buckley M, Christos PJ, Wright JJ, Polsky D, Osman I, Liebes L, Pavlick AC. Ott PA, et al. PLoS One. 2010 Dec 29;5(12):e15588. doi: 10.1371/journal.pone.0015588. PLoS One. 2010. PMID: 21206909 Free PMC article. Clinical Trial.

7

Enrollment in clinical trials correlates with improved survival in metastatic melanoma.

Seetharamu N, Tu TJ, Christos P, Ott PA, Berman RS, Shapiro RL, Osman I, Pavlick AC. Seetharamu N, et al. Among authors: ott pa. Oncology. 2011;81(5-6):403-9. doi: 10.1159/000335000. Epub 2012 Jan 20. Oncology. 2011. PMID: 22270052

8

Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node.

Ma MW, Medicherla RC, Qian M, Vega-Saenz de Miera E, Friedman EB, Berman RS, Shapiro RL, Pavlick AC, Ott PA, Bhardwaj N, Shao Y, Osman I, Darvishian F. Ma MW, et al. Among authors: ott pa. Mod Pathol. 2012 Jul;25(7):1000-10. doi: 10.1038/modpathol.2012.43. Epub 2012 Mar 16. Mod Pathol. 2012. PMID: 22425909 Free PMC article.

9

Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma.

Ott PA, Carvajal RD, Pandit-Taskar N, Jungbluth AA, Hoffman EW, Wu BW, Bomalaski JS, Venhaus R, Pan L, Old LJ, Pavlick AC, Wolchok JD. Ott PA, et al. Invest New Drugs. 2013 Apr;31(2):425-34. doi: 10.1007/s10637-012-9862-2. Epub 2012 Aug 5. Invest New Drugs. 2013. PMID: 22864522 Free PMC article. Clinical Trial.

10

Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial.

Ott PA, Chang J, Madden K, Kannan R, Muren C, Escano C, Cheng X, Shao Y, Mendoza S, Gandhi A, Liebes L, Pavlick AC. Ott PA, et al. Cancer Chemother Pharmacol. 2013 Jan;71(1):183-91. doi: 10.1007/s00280-012-1995-7. Epub 2012 Oct 12. Cancer Chemother Pharmacol. 2013. PMID: 23064957 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters